Format
Sort by

Send to

Choose Destination

Links from PubMed

Items: 1 to 20 of 115

1.

Developing a data mining approach to investigate association between physician prescription and patient outcome - a study on re-hospitalization in Stevens-Johnson Syndrome.

Ou-Yang C, Agustianty S, Wang HC.

Comput Methods Programs Biomed. 2013 Oct;112(1):84-91. doi: 10.1016/j.cmpb.2013.07.004.

PMID:
23910224
2.

Spontaneous adverse event reports of Stevens-Johnson syndrome/toxic epidermal necrolysis: detecting associations with medications.

Papay J, Yuen N, Powell G, Mockenhaupt M, Bogenrieder T.

Pharmacoepidemiol Drug Saf. 2012 Mar;21(3):289-96. doi: 10.1002/pds.2276.

PMID:
22139991
3.

Common risk allele in aromatic antiepileptic-drug induced Stevens-Johnson syndrome and toxic epidermal necrolysis in Han Chinese.

Hung SI, Chung WH, Liu ZS, Chen CH, Hsih MS, Hui RC, Chu CY, Chen YT.

Pharmacogenomics. 2010 Mar;11(3):349-56. doi: 10.2217/pgs.09.162.

PMID:
20235791
4.

Identification of Stevens-Johnson syndrome and toxic epidermal necrolysis in electronic health record databases.

Davis RL, Gallagher MA, Asgari MM, Eide MJ, Margolis DJ, Macy E, Burmester JK, Selvam N, Boscarino JA, Cromwell LF, Feigelson HS, Kuntz JL, Pawloski PA, Penfold RB, Raebel MA, Sridhar G, Wu A, La Grenade LA, Pacanowski MA, Pinheiro SP.

Pharmacoepidemiol Drug Saf. 2015 Jul;24(7):684-92. doi: 10.1002/pds.3778.

PMID:
25914229
5.

Causes and treatment outcomes of Stevens-Johnson syndrome and toxic epidermal necrolysis in 82 adult patients.

Kim HI, Kim SW, Park GY, Kwon EG, Kim HH, Jeong JY, Chang HH, Lee JM, Kim NS.

Korean J Intern Med. 2012 Jun;27(2):203-10. doi: 10.3904/kjim.2012.27.2.203.

6.

[Stevens-Johnson syndrome and toxic epidermal necrolysis in Lomé (Togo). Evolutional and etiological profiles of 40 cases].

Pitché P, Padonou CS, Kombate K, Mouzou T, Tchangai-Walla K.

Ann Dermatol Venereol. 2005 Jun-Jul;132(6-7 Pt 1):531-4. French.

PMID:
16142100
7.

Stevens-Johnson syndrome: pathogenesis, diagnosis, and management.

Hazin R, Ibrahimi OA, Hazin MI, Kimyai-Asadi A.

Ann Med. 2008;40(2):129-38. doi: 10.1080/07853890701753664. Review.

PMID:
18293143
8.

Data Mining FAERS to Analyze Molecular Targets of Drugs Highly Associated with Stevens-Johnson Syndrome.

Burkhart KK, Abernethy D, Jackson D.

J Med Toxicol. 2015 Jun;11(2):265-73. doi: 10.1007/s13181-015-0472-1.

9.

Toxic epidermal necrolysis and Stevens-Johnson syndrome.

Harr T, French LE.

Orphanet J Rare Dis. 2010 Dec 16;5:39. doi: 10.1186/1750-1172-5-39. Review.

10.

Stevens-Johnson syndrome and toxic epidermal necrolysis in sub-Saharan Africa: a multicentric study in four countries.

Saka B, Barro-Traoré F, Atadokpédé FA, Kobangue L, Niamba PA, Adégbidi H, Yedomon HG, Traoré A, Pitché VP.

Int J Dermatol. 2013 May;52(5):575-9. doi: 10.1111/j.1365-4632.2012.05743.x.

PMID:
23330601
11.

Risk of Stevens-Johnson syndrome and toxic epidermal necrolysis in new users of antiepileptics.

Mockenhaupt M, Messenheimer J, Tennis P, Schlingmann J.

Neurology. 2005 Apr 12;64(7):1134-8.

PMID:
15824335
12.
13.

Carbamazepine--the commonest cause of toxic epidermal necrolysis and Stevens-Johnson syndrome: a study of 7 years.

Devi K, George S, Criton S, Suja V, Sridevi PK.

Indian J Dermatol Venereol Leprol. 2005 Sep-Oct;71(5):325-8.

14.
15.

Erythema multiforme, Stevens-Johnson syndrome, and toxic epidermal necrolysis: acute ocular manifestations, causes, and management.

Chang YS, Huang FC, Tseng SH, Hsu CK, Ho CL, Sheu HM.

Cornea. 2007 Feb;26(2):123-9.

PMID:
17251797
16.

Stevens-Johnson syndrome and HIV in children in Swaziland.

Dziuban EJ, Hughey AB, Stewart DA, Blank DA, Kochelani D, Draper HR, Schutze GE.

Pediatr Infect Dis J. 2013 Dec;32(12):1354-8. doi: 10.1097/INF.0b013e31829ec8e5.

PMID:
23743542
17.

Drug-induced Stevens-Johnson syndrome/toxic epidermal necrolysis.

Fritsch PO, Sidoroff A.

Am J Clin Dermatol. 2000 Nov-Dec;1(6):349-60. Review.

PMID:
11702611
18.

Stevens-johnson syndrome associated with drugs and vaccines in children: a case-control study.

Raucci U, Rossi R, Da Cas R, Rafaniello C, Mores N, Bersani G, Reale A, Pirozzi N, Menniti-Ippolito F, Traversa G; Italian Multicenter Study Group For Vaccine Safety In Drug And Children..

PLoS One. 2013 Jul 16;8(7):e68231. doi: 10.1371/journal.pone.0068231.

19.

A European study of HLA-B in Stevens-Johnson syndrome and toxic epidermal necrolysis related to five high-risk drugs.

Lonjou C, Borot N, Sekula P, Ledger N, Thomas L, Halevy S, Naldi L, Bouwes-Bavinck JN, Sidoroff A, de Toma C, Schumacher M, Roujeau JC, Hovnanian A, Mockenhaupt M; RegiSCAR study group..

Pharmacogenet Genomics. 2008 Feb;18(2):99-107. doi: 10.1097/FPC.0b013e3282f3ef9c.

PMID:
18192896
20.

Stevens-Johnson syndrome and toxic epidermal necrolysis-challenges of recognition and management.

Sane SP, Bhatt AD.

J Assoc Physicians India. 2000 Oct;48(10):999-1003. Review.

PMID:
11200928
Items per page

Supplemental Content

Support Center